Suppr超能文献

相似文献

1
Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.
Cancer Immunol Immunother. 2011 Apr;60(4):525-35. doi: 10.1007/s00262-010-0961-7. Epub 2011 Jan 5.
9
Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis.
J Natl Cancer Inst. 2006 Feb 1;98(3):181-9. doi: 10.1093/jnci/djj020.
10
STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients.
Cancer Immunol Res. 2015 Aug;3(8):936-45. doi: 10.1158/2326-6066.CIR-15-0053. Epub 2015 May 13.

引用本文的文献

1
The regulatory role and mechanism of energy metabolism and immune response in head and neck cancer.
Genes Dis. 2025 Mar 19;12(6):101607. doi: 10.1016/j.gendis.2025.101607. eCollection 2025 Nov.
4
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit.
Cancers (Basel). 2024 Jan 11;16(2):312. doi: 10.3390/cancers16020312.
6
Immune escape of head and neck cancer mediated by the impaired MHC-I antigen presentation pathway.
Oncogene. 2024 Feb;43(6):388-394. doi: 10.1038/s41388-023-02912-2. Epub 2024 Jan 4.
8
Loss of Human Leukocyte Antigen and Immune Escape in Head and Neck Cancer.
Laryngoscope. 2024 Jan;134(1):160-165. doi: 10.1002/lary.30761. Epub 2023 May 30.
9
Immunomodulatory Therapy in Head and Neck Squamous Cell Carcinoma: Recent Advances and Clinical Prospects.
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338221150559. doi: 10.1177/15330338221150559.
10
Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises.
Explor Target Antitumor Ther. 2022;3(6):746-762. doi: 10.37349/etat.2022.00111. Epub 2022 Dec 22.

本文引用的文献

1
CD8+ T cell recognition of polymorphic wild-type sequence p53(65-73) peptides in squamous cell carcinoma of the head and neck.
Cancer Immunol Immunother. 2010 Oct;59(10):1561-8. doi: 10.1007/s00262-010-0886-1. Epub 2010 Jun 25.
2
Serum prognostic markers in head and neck cancer.
Clin Cancer Res. 2010 Feb 1;16(3):1008-15. doi: 10.1158/1078-0432.CCR-09-2014. Epub 2010 Jan 26.
4
Different regulation of MHC class I antigen processing components in human tumors.
J Immunotoxicol. 2008 Oct;5(4):361-7. doi: 10.1080/15476910802482870.
5
IFNgamma signaling-does it mean JAK-STAT?
Cytokine Growth Factor Rev. 2008 Oct-Dec;19(5-6):383-94. doi: 10.1016/j.cytogfr.2008.08.004. Epub 2008 Oct 16.
6
HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance.
Oncogene. 2008 Oct 6;27(45):5869-85. doi: 10.1038/onc.2008.273.
7
Inhibition of IFN-gamma-induced STAT1 tyrosine phosphorylation by human CMV is mediated by SHP2.
J Immunol. 2008 Oct 15;181(8):5530-6. doi: 10.4049/jimmunol.181.8.5530.
8
Interleukin-6 predicts recurrence and survival among head and neck cancer patients.
Cancer. 2008 Aug 15;113(4):750-7. doi: 10.1002/cncr.23615.
9
Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity.
Exp Cell Res. 2007 Nov 15;313(19):4015-24. doi: 10.1016/j.yexcr.2007.08.007. Epub 2007 Aug 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验